Medidata Solutions Inc. (NASDAQ:MDSO) President Vries Glen Michael De sold 7,500 shares of Medidata Solutions stock in a transaction dated Wednesday, November 9th. The shares were sold at an average price of $50.85, for a total value of $381,375.00. Following the completion of the sale, the president now owns 939,017 shares of the company’s stock, valued at $47,749,014.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Vries Glen Michael De also recently made the following trade(s):

  • On Tuesday, October 11th, Vries Glen Michael De sold 7,500 shares of Medidata Solutions stock. The shares were sold at an average price of $54.72, for a total value of $410,400.00.
  • On Monday, September 12th, Vries Glen Michael De sold 7,500 shares of Medidata Solutions stock. The shares were sold at an average price of $53.70, for a total value of $402,750.00.

Shares of Medidata Solutions Inc. (NASDAQ:MDSO) opened at 53.30 on Monday. Medidata Solutions Inc. has a 12 month low of $30.22 and a 12 month high of $57.21. The company has a 50-day moving average price of $51.74 and a 200-day moving average price of $49.71. The stock has a market cap of $2.97 billion, a price-to-earnings ratio of 121.69 and a beta of 1.49.

Medidata Solutions (NASDAQ:MDSO) last posted its earnings results on Tuesday, October 25th. The company reported $0.28 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.26 by $0.02. Medidata Solutions had a return on equity of 10.46% and a net margin of 5.70%. The firm had revenue of $120.10 million for the quarter, compared to analyst estimates of $118.96 million. During the same quarter in the prior year, the company earned $0.25 EPS. Medidata Solutions’s revenue was up 16.5% on a year-over-year basis. On average, analysts expect that Medidata Solutions Inc. will post $1.02 EPS for the current fiscal year.

Insider Buying and Selling by Quarter for Medidata Solutions (NASDAQ:MDSO)

Several research firms have issued reports on MDSO. Jefferies Group lifted their target price on Medidata Solutions from $36.00 to $41.00 and gave the company an “underperform” rating in a research note on Wednesday, October 26th. Wells Fargo & Co. lowered Medidata Solutions from an “outperform” rating to a “market perform” rating in a research note on Thursday, July 21st. Morgan Stanley reiterated a “buy” rating and issued a $61.00 target price on shares of Medidata Solutions in a research note on Thursday, August 25th. Needham & Company LLC reiterated a “buy” rating and issued a $60.00 target price (up previously from $55.00) on shares of Medidata Solutions in a research note on Sunday, July 24th. Finally, Deutsche Bank AG lifted their target price on Medidata Solutions from $56.00 to $58.00 and gave the company a “buy” rating in a research note on Tuesday, September 13th. One analyst has rated the stock with a sell rating, two have issued a hold rating and nine have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $54.30.

A number of institutional investors have recently bought and sold shares of MDSO. State Street Corp raised its stake in Medidata Solutions by 3.7% in the first quarter. State Street Corp now owns 1,154,085 shares of the company’s stock worth $44,675,000 after buying an additional 40,827 shares in the last quarter. BlackRock Institutional Trust Company N.A. raised its stake in Medidata Solutions by 1.0% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 1,359,364 shares of the company’s stock worth $52,621,000 after buying an additional 13,786 shares in the last quarter. Teachers Advisors Inc. raised its stake in Medidata Solutions by 0.9% in the first quarter. Teachers Advisors Inc. now owns 91,369 shares of the company’s stock worth $3,537,000 after buying an additional 778 shares in the last quarter. BlackRock Group LTD raised its stake in Medidata Solutions by 9.0% in the first quarter. BlackRock Group LTD now owns 71,429 shares of the company’s stock worth $2,765,000 after buying an additional 5,907 shares in the last quarter. Finally, Eqis Capital Management Inc. bought a new stake in Medidata Solutions during the second quarter worth about $292,000.

Medidata Solutions Company Profile

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Medidata Clinical Cloud provides a platform of technology and data analytics solutions designed to manage activities across clinical development.

5 Day Chart for NASDAQ:MDSO

Receive News & Stock Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related stocks with our FREE daily email newsletter.